Please assess the completion status of the following clinical trial:

Trial Title: Impact of Mupirocin Decolonization on the Nasal Microbiome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria: - Patients at VA-ECHCS who are starting a course of nasal mupirocin therapy for S. aureus decolonization~Exclusion Criteria:~Age \< 18 years Pregnant women Prisoners Decisionally challenged subjects

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Staphylococcus aureus nasal carriers (Type: None): Patients who are treated with mupirocin to clear nasal colonization with Staphylococcus aureus

Based on this trial design, predict the completion outcome and termination type (if applicable).